Journal profile · ONCOLOGY

Journal of the Egyptian National Cancer Institute

ISSN 1110-0362 · eISSN 2589-0409 · SpringerOpen · United Kingdom

Journal of the Egyptian National Cancer Institute: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; median 139 days to acceptance (102 articles, last 24 months); 81 articles in 2025; indexed in ESCI and Scopus.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time139 daysMedian, submission to acceptance · 102 articles, last 24 months · PubMed
APCNo APCDiamond open access (no APC)
Acceptance—No reports yet
Articles per year812025 · OpenAlex count

Scope

Aims, scope and focus

Journal of the Egyptian National Cancer Institute is published by SpringerOpen and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers and Head and Neck Cancer Studies, together about 19.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Read the latest articles of Journal of the Egyptian National Cancer Institute at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

From the journal's Aims & Scope

Research area (LetPub): ONCOLOGY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology9.2%
  2. Cancer Immunotherapy and BiomarkersMedicine5.4%
  3. Head and Neck Cancer StudiesMedicine5%
  4. Endometrial and Cervical Cancer TreatmentsMedicine4.9%
  5. Lymphoma Diagnosis and TreatmentMedicine4.7%
  6. Sarcoma Diagnosis and TreatmentMedicine4.5%
  7. Advanced Radiotherapy TechniquesPhysics and Astronomy4.5%
  8. Ferroptosis and cancer prognosisMedicine4.2%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorOncologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
3.2LetPub ·
SJR 2026-06
0.55LetPub ·
SNIP 2026-06
0.78LetPub ·
h-index
36OpenAlex ·
i10-index
226OpenAlex ·
2-year mean citedness
2.16OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
80LetPub ·

Articles by year OpenAlex count · 710 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026777711
20258181224
20244444201
20234444290
20225757551
20214040547

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

139 daysMedian, submission to acceptance · P25–P75 86 days – 240 days

Acceptance to online
median 30 days (102 articles)
Submission to online
median 178 days
Sample
102 articles with submission and acceptance dates (172 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 11 weeksLetPub ·
Submission to publication (journal-reported)
about 11 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY, CC BY-NC-ND
OpenAlexUSD 0——
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
SpringerOpen
Country or region
United Kingdom
Language
English
ISSN
1110-0362
Electronic ISSN
2589-0409
Official links

FAQ

Frequently asked questions about Journal of the Egyptian National Cancer Institute

What CAS zone is Journal of the Egyptian National Cancer Institute in?

In the 2025 upgraded edition of the CAS Journal Ranking, Journal of the Egyptian National Cancer Institute is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Journal of the Egyptian National Cancer Institute?

Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 139 days (interquartile range 86–240 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Journal of the Egyptian National Cancer Institute?

According to LetPub and DOAJ records, Journal of the Egyptian National Cancer Institute is indexed in ESCI, Scopus and DOAJ.

Is Journal of the Egyptian National Cancer Institute open access, and what is the APC?

Journal of the Egyptian National Cancer Institute is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .